Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul D Bryson

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Vaccine|September 17, 2017
Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growthPaul D Bryson, Xiaolu Han, Norman Truong, et al.
Journal of Visualized Experiments : Jove|July 16, 2013
A tetracycline-regulated cell line produces high-titer lentiviral vectors that specifically target dendritic cellsPaul D Bryson, Chupei Zhang, Chi-Lin Lee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2012
PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccinesBingbing Dai, Liang Xiao, Paul D Bryson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2005
The evolutionary origin of a complex scrambled geneWei-Jen Chang, Paul D Bryson, Han Liang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Masked Chimeric Antigen Receptor for Tumor-Specific ActivationXiaolu Han, Paul D Bryson, Yifan Zhao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 19, 2017
Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug CarriersElizabeth L Siegler, Yu Jeong Kim, Xianhui Chen, et al.
Nature Biotechnology|September 2, 2008
Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysisShirit Einav, Doron Gerber, Paul D Bryson, et al.
Antiviral Research|April 6, 2010
A small molecule inhibits HCV replication and alters NS4B's subcellular distributionPaul D Bryson, Nam-Joon Cho, Shirit Einav, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Vaccine|September 17, 2017
Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growthPaul D Bryson, Xiaolu Han, Norman Truong, et al.
Journal of Visualized Experiments : Jove|July 16, 2013
A tetracycline-regulated cell line produces high-titer lentiviral vectors that specifically target dendritic cellsPaul D Bryson, Chupei Zhang, Chi-Lin Lee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2012
PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccinesBingbing Dai, Liang Xiao, Paul D Bryson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2005
The evolutionary origin of a complex scrambled geneWei-Jen Chang, Paul D Bryson, Han Liang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Masked Chimeric Antigen Receptor for Tumor-Specific ActivationXiaolu Han, Paul D Bryson, Yifan Zhao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 19, 2017
Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug CarriersElizabeth L Siegler, Yu Jeong Kim, Xianhui Chen, et al.
Nature Biotechnology|September 2, 2008
Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysisShirit Einav, Doron Gerber, Paul D Bryson, et al.
Antiviral Research|April 6, 2010
A small molecule inhibits HCV replication and alters NS4B's subcellular distributionPaul D Bryson, Nam-Joon Cho, Shirit Einav, et al.
Pageof 1